Cepheid has secured FDA clearance for an enhanced version of its Xpert MRSA/SA Blood Culture assay, which is used with the company's GeneXpert System. The test analyzes positive blood culture samples to detect methicillin-resistant Staphylococcus aureus and Staphylococcus aureus infections, which often trigger sepsis during hospital stays.

Related Summaries